130 likes | 368 Views
The New Generation of Essential Medicines: Vietnam…now. Dr Socorro Escalante Technical Officer-Pharmaceuticals Country Office for Vietnam. Access to essential medicines in Vietnam is shaped partly by the need and vision for health , and more so by its political and economic development.
E N D
The New Generation of Essential Medicines: Vietnam…now Dr Socorro Escalante Technical Officer-Pharmaceuticals Country Office for Vietnam WHO Country Office for Viet Nam
Access to essential medicines in Vietnam is shaped partly by the need and vision for health , and more so by its political and economic development WHO Country Office for Viet Nam
Vietnam Now: key events leading to the present situation Doi moi Decentralization Donor Presence WTO Hospital Reforms 1980’s 1996 2000’s 2007 2008 WHO Country Office for Viet Nam
Outcomes and impact to medicines access WHO Country Office for Viet Nam
Current Issues that need attention Prices Inequities Quality and Safety Medicines Use Policy Coherence WHO Country Office for Viet Nam
Current Issues that need attention Prices of Medicine Table 2. MPR across countries in Asia Source: Data retrieved from WHO/HAI Medicines Prices Database: WHO Country Office for Viet Nam
Current Issues that need attention WHO Country Office for Viet Nam
Current Issues that need attention Inefficient procurement systems that impacts on medicines expenditures Fig 7. Price variation of winning bid prices across hospitals for Gliclalazide, 80 mg Source: Analysis of hospital procurement data, 2009, WCO Vietnam WHO Country Office for Viet Nam
Strategic response and directions…by the Government • Socio Economic Development Plan • Pharmaceutical law • Local production policy • Drug price control • National Medicines Policy • Essential Medicines List • 5 Good Practices Program WHO Country Office for Viet Nam
Strategic response and directions: The new generation Guiding principles: • Policy coherence: Action beyond the health sector • National-local : Oversight and guidance rather than just regulations and control • Evidence: appreciation and relevance into decision making • Donors: from ‘my fund, my system’ to ‘our fund, our system’ WHO Country Office for Viet Nam
Strategic response and directions: The new generation WHO Country Office for Viet Nam
Remaining Challenges: Where are we stuck? 1. Policy coherence: NMP envisaged to bring about policy coherence in pharmaceuticals 2. Operational reforms: • neglected partly but have direct impact into access and inequalities • Procurement inefficiencies and medicines utilization in hospital 3. Coordination across agencies and donors 4. Drug Price Control Policies WHO Country Office for Viet Nam
thank you WHO Country Office for Viet Nam